The molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and disease

C Goul, R Peruzzo, R Zoncu - Nature Reviews Molecular Cell Biology, 2023 - nature.com
Abstract The Ser/Thr kinase mechanistic target of rapamycin (mTOR) is a central regulator of
cellular metabolism. As part of mTOR complex 1 (mTORC1), mTOR integrates signals such …

Non-canonical mTORC1 signaling at the lysosome

G Napolitano, C Di Malta, A Ballabio - Trends in Cell Biology, 2022 - cell.com
The mechanistic target of rapamycin complex 1 (mTORC1) signaling hub integrates multiple
environmental cues to modulate cell growth and metabolism. Over the past decade …

Amplification of human interneuron progenitors promotes brain tumors and neurological defects

OL Eichmüller, NS Corsini, Á Vértesy, I Morassut… - Science, 2022 - science.org
Evolutionary development of the human brain is characterized by the expansion of various
brain regions. Here, we show that developmental processes specific to humans are …

[PDF][PDF] A synaptic perspective of fragile X syndrome and autism spectrum disorders

C Bagni, RS Zukin - Neuron, 2019 - cell.com
Altered synaptic structure and function is a major hallmark of fragile X syndrome (FXS),
autism spectrum disorders (ASDs), and other intellectual disabilities (IDs), which are …

Molecular logic of mTORC1 signalling as a metabolic rheostat

AJ Valvezan, BD Manning - Nature metabolism, 2019 - nature.com
The protein kinase complex mechanistic target of rapamycin complex 1 (mTORC1) serves
as a key conduit between growth signals and the metabolic processes underlying cell …

Epilepsy in the mTORopathies: opportunities for precision medicine

PB Moloney, GL Cavalleri, N Delanty - Brain communications, 2021 - academic.oup.com
The mechanistic target of rapamycin signalling pathway serves as a ubiquitous regulator of
cell metabolism, growth, proliferation and survival. The main cellular activity of the …

The metabolic basis of kidney cancer

WM Linehan, LS Schmidt, DR Crooks, D Wei… - Cancer Discovery, 2019 - AACR
Kidney cancer is not a single disease but represents several distinct types of cancer that
have defining histologies and genetic alterations and that follow different clinical courses …

[HTML][HTML] mTOR inhibitors in cancer therapy

J Xie, X Wang, CG Proud - F1000Research, 2016 - ncbi.nlm.nih.gov
The mammalian target of rapamycin, mTOR, plays key roles in cell growth and proliferation,
acting at the catalytic subunit of two protein kinase complexes: mTOR complexes 1 and 2 …

Tumour predisposition and cancer syndromes as models to study gene–environment interactions

M Carbone, ST Arron, B Beutler, A Bononi… - Nature Reviews …, 2020 - nature.com
Cell division and organismal development are exquisitely orchestrated and regulated
processes. The dysregulation of the molecular mechanisms underlying these processes …

[HTML][HTML] Aberrant T cell signaling and subsets in systemic lupus erythematosus

T Katsuyama, GC Tsokos, VR Moulton - Frontiers in immunology, 2018 - frontiersin.org
Systemic lupus erythematosus (SLE) is a chronic multi-organ debilitating autoimmune
disease, which mainly afflicts women in the reproductive years. A complex interaction of …